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Summary
Post-translational phosphorylation of proteins provides a
mechanism for cells to switch on or off many diverse
processes, including responses to replication stress.
Replication-stress-induced phosphorylation enables the
rapid activation of numerous proteins involved in DNA
replication, DNA repair and cell cycle checkpoints,
including replication protein A (RPA). Here, we report that
hydroxyurea (HU)-induced RPA phosphorylation requires
both NBS1 (NBN) and NBS1 phosphorylation.
Transfection of both phosphospecific and nonphosphospecific
anti-NBS1
antibodies
blocked
hyperphosphorylation of RPA in HeLa cells. Nijmegen
breakage syndrome (NBS) cells stably transfected with an
empty vector or with S343A-NBS1 or S278A/S343A
phospho-mutants were unable to hyperphosphorylate RPA
in DNA-damage-associated foci following HU treatment.
The stable transfection of fully functional NBS1 in NBS

Introduction
Cell, organism and species survival depend on the fidelity of
DNA replication. Therefore, it is not surprising that highly
complex surveillance mechanisms, consisting of DNA repair,
DNA replication and checkpoint proteins, have evolved to
maintain genomic integrity. Stalled replication forks pose a
grave threat to cell survival and genomic integrity (Kolodner
et al., 2002). Therefore, understanding how cells cope with
aberrant replication forks is essential to understanding the
mechanisms of genome maintenance. A key component of the
cellular response to stalled replication includes the
localization of an intricate set of DNA-repair and checkpoint
proteins to sites surrounding DNA lesions in a precise and
cohesive manner (van den Bosch et al., 2003). These large
aggregates of proteins form dynamic multi-tiered structures
known as foci (Bishop, 1994; Lisby and Rothstein, 2004).
Using indirect immunofluorescence microscopy, these foci
are observed as brightly colored spots within the nucleus.
Examples of proteins in these foci include DNA-damage
sensors such as H2AX (H2AFX), RAD9-HUS1-RAD9, RPA

cells restored RPA hyperphosphorylation. Retention of
ATR on chromatin in both NBS cells and in NBS cells
expressing S278A/S343A NBS1 mutants decreased after
DNA damage, suggesting that ATR is the kinase responsible
for RPA phosphorylation. The importance of RPA
hyperphosphorylation is demonstrated by the ability of
cells expressing a phospho-mutant form of RPA32 (RPA2)
to suppress and delay HU-induced apoptosis. Our findings
suggest that RPA hyperphosphorylation requires NBS1 and
is important for the cellular response to DNA damage.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/120/23/4221/DC1
Key words: Phosphorylation, DNA-damage response, DNA repair,
Replication-fork stall, Replication stress

and MRE11-RAD50-NBS1 (MRN; NBS1 is also known as
NBN); proximal kinases such as ATR and ATM; and adaptor
proteins such as 53BP1 (TP53BP1), MDC1, BRCA1 and
claspin; effector kinases such as CHK1 (CHEK1) and CHK2
(CHEK2); the homologous-recombination proteins RAD51
paralogs and RAD52; and the end-joining proteins ARTEMIS
(DCLRE1C), KU70 (XRCC6), KU80 (XRCC5), DNA-PK
and XRCC4 (Fernandez-Capetillo et al., 2003; Lisby et al.,
2004; Riballo et al., 2004; Rouse and Jackson, 2002).
The assembly and disassembly of these aggregates appears
to be directed by protein-protein interactions rather than by
direct binding of each protein to the DNA lesion (Lisby et al.,
2004). Depending on the type of lesion, specific proteins
needed to sense and repair the lesion are recruited. The rapid
initial recruitment of proteins is tightly regulated and
phosphorylation is a crucial post-translational modification
that can rapidly change the interaction of proteins. For
example, DNA-damage-dependent phosphorylation of
BACH1 is required for its interaction with BRCA1 (Yu et al.,
2003).
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The conserved proteins MRE11, RAD50 and NBS1 have
central roles in both DNA replication and DNA repair, and are
essential in maintaining genomic stability and function.
Evidence that implicates the involvement of the MRN
complex in normal DNA replication includes the requirement
of the MRN complex to prevent DNA double-strand breaks
during normal replication and its co-localization with PCNA
throughout S-phase (Costanzo et al., 2001; Mirzoeva and
Petrini, 2003). It has also been shown that NBS1 binds to E2F
transcription factors and directs the MRN complex to origins
of replication; this data suggests a role for NBS1 in the
processing of secondary structures formed during the
initiation of DNA synthesis and normal fork progression
(Maser et al., 2001). Mutations within the human genes
MRE11 and NBS1 cause the human disorders ataxia
telangiectasia-like disorder and Nijmegen breakage syndrome,
respectively (Carney et al., 1998; Stewart et al., 1999; Varon
et al., 1998). Cells derived from individuals with these
disorders display multiple DNA-damage-response defects,
including chromosomal fragility, the inability to arrest DNA
replication after DNA damage, hypersensitivity to DNAdamaging agents and defective checkpoint responses
(D’Amours and Jackson, 2002).
Previous studies have shown that RPA, a heterotrimeric
single-stranded-DNA-binding protein, is involved in the
initiation of DNA replication and remains localized to
replication forks during elongation in S-phase (Brill and
Stillman, 1989; Dimitrova et al., 1999; Liu et al., 2003;
Fairman and Stillman, 1988; Wold and Kelly, 1988). The
middle subunit of RPA, RPA32, is phosphorylated primarily at
two sites, serine 23 and serine 29, during the normal cell cycle
in the G1/S transition, G2 and M-phase, followed by
dephosphorylation at the end of M-phase (Din et al., 1990).
DNA-damaging agents known to stall replication, including
UV, inhibitors of topoisomerase I and II and hydroxyurea
(HU), induce hyperphosphorylation of RPA at additional
serines and threonines on the N-terminus of RPA32, including
serines 4, 8 and 33 and threonine 21 (Block et al., 2004; Nuss
et al., 2005; Zernik-Kobak et al., 1997). RPA phosphorylation
is thought to modulate protein-protein interactions as well as
its ability to bind dsDNA (Abramova et al., 1997; Binz et al.,
2003; Liu et al., 2005; Patrick et al., 2005; Yoo et al., 2005).
RPA hyperphosphorylation, either via its effect on proteinprotein interactions or on DNA-binding ability, decreases RPA
involvement in replication (Carty et al., 1994; Olson et al.,
2006) and regulates RPA functions in mismatch repair (Guo et
al., 2006).
Both RPA and the MRN complex co-localize to discrete foci
and interact in response to DNA replication-fork collapse
induced by HU and UV (Robison et al., 2004). Here, we
demonstrate that HU-induced RPA hyperphosphorylation
requires NBS1. In cells lacking NBS1 expression or expressing
S343A NBS1 protein, RPA in HU-induced foci was not
hyperphosphorylated. Our results suggest that ATR is the
kinase responsible for HU-induced RPA hyperphosphorylation
and support the model that NBS1 is crucial for ATR retention
at the sites of HU-induced DNA damage. Cells that lacked
RPA32 hyperphosphorylation exhibited a decreased and
delayed apoptotic response following HU treatment,
suggesting an important role for RPA hyperphosphorylation in
the cellular response to DNA damage.

Results
Functional NBS1 is required for RPA
hyperphosphorylation at repair foci
It has been shown previously that RPA interacts with the MRN
complex at sites of DNA damage (Olson et al., 2007; Robison
et al., 2004). To determine the DNA-damage-dependent
interactions of NBS1 and phosphorylated NBS1 on RPA, we
examined HU-induced hyperphosphorylation of RPA32 in
HeLa cells after blocking endogenous NBS1 with the
introduction of an anti-NBS1 antibody, which detects both
unphosphorylated and phosphorylated NBS1 (supplementary
material Fig. S1). Chariot transfection procedures did not affect
normal cell cycle progression, as verified by flow cytometry
(supplementary material Fig. S2). With the peptide-mediated
transfection of control non-immune IgG protein,
hyperphosphorylated RPA foci were visible in approximately
30% of the cells following HU treatment. The peptidemediated transfection of anti-NBS1 antibodies resulted in a
decrease of RPA32 hyperphosphorylation at DNA-damage foci
to mock-treated levels, whereas the recruitment of
unphosphorylated RPA32 to the sites of damage remained
unchanged (Fig. 1J-L). In a similar manner, the introduction of
phospho-specific antibodies against NBS1 phosphorylated at
serine 343 [anti-NBS1-S(P)343] into HeLa cells decreased
hyperphosphorylation of RPA32 at DNA-damage foci
following HU treatment (Fig. 1A,P-R).
Similar to HeLa cells blocked with NBS1 antibodies, cells
lacking fully functional NBS1 exhibited decreased
hyperphosphorylation of RPA at DNA-damage foci upon HU
treatment, whereas the overall recruitment of RPA32 to foci
was not altered (Fig. 2J-L). Expression of fully functional
NBS1 activated hyperphosphorylation of RPA32 at DNAdamage foci to a similar level observed in HeLa cells (Fig. 2DF), whereas cells expressing phospho-mutant NBS1 protein
(S343A) demonstrated impaired phosphorylation, similar to
cells lacking fully functional NBS1.
Western blot shows that HU-induced RPA
hyperphosphorylation is impaired in NBS cell lines and
in NBS1 phospho-mutant cell lines
A decrease of RPA32 hyperphosphorylation in NBS cells
expressing phospho-mutant NBS1 (S343A) (Fig. 2) and in
HeLa cells transfected with anti-NBS1-S(P)343 antibodies
(Fig. 1) suggests a requirement for NBS1 phosphorylation as a
prerequisite for hyperphosphorylation of RPA32. To further
characterize the relationship between NBS1 phosphorylation
and RPA32 hyperphosphorylation, we compared NBS cells
restored with full-length NBS1 to NBS cells containing an
empty vector or expressing phospho-mutant forms of NBS1
(S343A and S278A/S343A) in their abilities to
hyperphosphorylate RPA32 using western blot analysis.
Because HU-induced replication stress is a cell-cycle-specific
effect, we synchronized the cells with aphidicolin before HU
treatment. Aphidicolin at low doses decreases the rate of fork
progression without activating checkpoints (Shimura et al.,
2007) and has been shown to be effective in cell
synchronization (Pedrali-Noy et al., 1980); this allowed for the
induction of RPA hyperphosphorylation at a lower dose of HU.
Consistent with foci data, RPA32 hyperphosphorylation was
absent in NBS cells expressing phospho-mutant forms of NBS1
and cells lacking NBS1 (Fig. 3A), whereas expression of wild-
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Fig. 1. Anti-NBS1 and anti-NBS1-S(P)343 block the formation of
RPA32-S(P)4-S(P)8 and RPA foci. (A-R) Following the introduction
of the negative-control IgG (A-F), anti-NBS1 (G-L) or anti-NBS1S(P)343 (M-R), HeLa cells were treated with 5 mM HU, or were
mock-treated (control), for 3 hours. Cells were detergent-extracted
and fixed, incubated with primary and secondary antibodies, and
visualized by confocal microscopy. (D-F) HU treatment led to
RPA32-S(P)4-S(P)8 (green) and RPA32 (red) focus formation in
negative-control IgG-transfected cells. (J-L,P-R) anti-NBS1- and antiNBS1-S(P)343-transfected cells contained RPA32 foci but RPA32S(P)4-S(P)8 foci were not observed. HU-induced damage was
verified by H2AX phosphorylation (supplementary material Fig. S4).

type NBS1 restored hyperphosphorylation of RPA32 to NBS
cells.
RPA redistributes to chromatin, but is not
hyperphosphorylated following HU treatment in cells
expressing catalytically impaired ATR
To understand the mechanism of the recruitment of RPA to sites
of damage and to identify the kinase responsible for
phosphorylation of RPA after replicative stress, we looked at
RPA recruitment and phosphorylation in ATR-kinase dead
(ATR-kd) and ATM deficient (A-T) cells. Consistent with
previous reports, HU treatment caused considerable
redistribution of RPA to the chromatin-bound fraction in A-T
cells, A-T cells expressing ATM, ATR wild-type cells and ATRkd cells (Fig. 3B), indicating that RPA recruitment to stalled
replication forks is independent of ATM and ATR (Balajee and
Geard, 2004; Liu et al., 2003; Stiff et al., 2005). The absence
of ATM did not affect RPA hyperphosphorylation; however,
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Fig. 2. Impaired formation of RPA32-S(P)4-S(P)8 foci in NBS-ILB1
(vector only) and NBS-ILB1 (S343A) cells. (A-R) The indicated
isogenic cell lines were treated with 5 mM HU for 3 hours prior to
detergent-extraction, fixation and immunofluorescence using
RPA32-S(P)4-S(P)8 (green) or RPA32 (red) antibodies. (D-F) HU
treatment induced RPA recruitment to sites of DNA damage and
normal RPA hyperphosphorylation occurred in NBS-ILB1 (NBS1)
cells. (J-L,P-R) NBS-ILB1 (vector only) and NBS-ILB1 (S343A)
cells recruited RPA to sites of DNA damage; however, RPA32 was
not phosphorylated at these sites. HU toxicities were comparable for
all cell lines tested (supplementary material Fig. S3).

overexpression of ATR-kd decreased hyperphosphorylation of
RPA bound to chromatin (Fig. 3B). This suggests that the
majority of hyperphosphorylation of chromatin-bound RPA
following HU-induced replicative stress is ATR dependent.
Decreased ATR chromatin retention in NBS1-deficient
and NBS1-phospho-mutant cells
It is probable that the kinase responsible for RPA
hyperphosphorylation following HU-induced DNA damage is
ATR, the kinase activity of which might also require fully
functional NBS1. This would suggest that the lack of RPA32
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intense in approximately 30-35% of the treated cells, whereas
ATR foci observed in NBS1-deficient and NBS1-phosphomutant cells were detectable at a much lower level, comparable
to control levels (Fig. 4A-R). The requirement of NBS1 for
ATR chromatin retention has been shown previously (Stiff et
al., 2005). To confirm the importance of NBS1
phosphorylation for ATR chromatin retention, we carried out
cell fractionation experiments, choosing the NBS1-corrected
and the NBS1 double-phospho-mutant (S278A/S343A) cells.
Compared with NBS1-corrected cells, weak ATR chromatin
retention could be observed in the double-phospho-mutant
cells in both untreated and HU-treated conditions, whereas
ATR chromatin retention in NBS1-corrected cells increased
slightly with HU treatment (Fig. 4S).

Fig. 3. NBS1 and ATR are required for RPA phosphorylation
following HU-induced replicative stress. (A) NBS-ILB1 (NBS1),
NBS-ILB1 (S343A), NBS-ILB1 (S278A/S343A) and NBS-ILB1
(LXIN, vector only) cells were synchronized with 6 M aphidicolin
for 16 hours. The medium was replaced with fresh medium for 3
hours before HU treatment. Following 3 hours of treatment with
2 mM HU, cells were harvested and chromatin fractions were
prepared. Proteins were detected by immunoblotting with the
corresponding antibodies. (B) Chromatin isolated from the A-T cell
line AT22IJE-T (ATM+) and its isogenic derivative cell line
expressing recombinant ATM (ATM–) showed little difference in
RPA-chromatin binding or RPA phosphorylation. Similar to the A-T
cell lines, U2OS cells expressing either wild-type ATR or kinasedead ATR (ATR-kd) displayed similar RPA-chromatin binding
following DNA damage. Distinct from A-T cells, ATR-kd
expression in U2OS cells significantly decreased RPA
hyperphosphorylation.

hyperphosphorylation might be due to impaired recruitment
and retention of ATR at the site of DNA damage. To test this
hypothesis, we compared NBS1-deficient and phosphomutant-NBS1 cells to NBS1-corrected cells for detergentextraction-resistant ATR binding. Cells were synchronized
with aphidicolin and released into fresh medium for 3 hours
prior to HU treatment. ATR foci in NBS1-corrected cells were
Fig. 4. HU-induced ATR foci and chromatin retention is decreased
both in NBS1-deficient and NBS1 phospho-mutant cells.
(A-R) NBS-ILB1 (NBS1), NBS-ILB1 (vector only) and NBS-ILB1
(S278A/S343A) cells were synchronized and treated with 2 mM HU
for 3 hours. To visualize detergent-resistant ATR foci, cells were
extracted with detergent before fixation. (D-F) In NBS cells restored
with wild-type NBS1, ATR foci (green) were still visible after
detergent extraction (D) and ATR foci colocalized with HU-induced
RPA32 foci (red) (F). (G-R) Decreased retention of ATR (J,P) and a
loss of colocalization with RPA (L,R) was observed in NBS1deficient and in NBS1 phospho-mutant cells. (S) ATR retention in
chromatin fractions of synchronized NBS-ILB1 (NBS1) and NBSILB1 (S278A/S343A) cells was examined by immunoblotting with
anti-ATR antibodies. NBS cells expressing NBS1 retained ATR in
the chromatin fractions, whereas NBS cells expressing a phosphomutant form of NBS1 (S278A/S343A) did not retain ATR in the
chromatin. Orc2-chromatin binding was not altered following DNA
damage and was used as a loading control.

NBS1-dependent phosphorylation of RPA
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HU-induced apoptosis is suppressed and delayed in
RPA32 S4A-S8A phospho-mutant cells
Among the identified phosphorylation sites on the N-terminus
of RPA32, S4 and S8 are unique in that their phosphorylation
is only observed following DNA damage (Patrick et al., 2005).
To examine the functional significance of RPA
phosphorylation in response to DNA damage, we retrovirally
infected UM-SCC38 cells with HA-tagged copies of wild-type
or S4A-S8A-mutant alleles of RPA32 (A4A8 RPA32).
Endogenous RPA32 was downregulated with siRNA directed
towards a 3⬘ UTR region of RPA32 mRNA, with recombinant
RPA32 protein expressed at similar levels to endogenous
protein (Fig. 5A). HA-RPA32, bound to anti-HA antibodies,

Fig. 5. Wild-type HA-RPA32-containing heterotrimers are
hyperphosphorylated following siRNA downregulation of
endogenous RPA32 and HU treatment. (A) SCC38 cells were
transfected with HA-wt-RPA32 (lanes 2,3) or HA-A4A8-RPA32
(lanes 3,4). Cells were treated with siRNA directed towards the 3⬘
non-coding sequence of RPA32 for 48 hours. Following siRNA
downregulation of endogenous RPA32, cells were subjected to HU
(5 mM) treatment for 3 hours. Lysates from either control or HUtreated cells were analyzed for the presence of RPA32 by western
blot analysis using RPA32 antibodies that recognize both
endogenous and transfected RPA32. The membrane was reblotted
without stripping with antibodies that recognize phosphorylated
S4S8 forms of RPA32 (bottom panel). (B) HA-tagged RPA32 formed
a complex with endogenous RPA70 and RPA14, as demonstrated by
co-immunoprecipitating HA-tagged RPA32. Lysates prepared from
UM-SCC38 cells transfected with an empty vector or HA-wt-RPA32
were subjected to immunoprecipitation using HA antibodies.
Immunoprecipitates were then analyzed for RPA70, RPA32 and
RPA14 by western blot analysis (lanes 1-2).
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efficiently immunoprecipitated both endogenous RPA70 and
RPA14 from lysates prepared from cells transfected with wildtype RPA32 and A4A8-RPA32, verifying that HA-RPA32 is
capable of forming a complex with the other RPA subunits
(Fig. 5B). Anti-HA antibodies did not immunoprecipitate
endogenous RPA70 and RPA14 from lysates derived from cells
transfected with an empty vector.
Another cellular response to the presence of overwhelming
DNA damage is the process of programmed cell death,
apoptosis. Staining with an Annexin-V–APC conjugate was
used for the detection of apoptotic cells by flow cytometry.
Cells were transfected with siRNA directed towards
endogenous RPA32 48 hours prior to HU treatment. Cells were
then treated for 24 hours with 2 mM HU then returned to fresh
medium. At 24 hours after HU treatment, over 25% of the wildtype-RPA32-expressing cells and uninfected cells transfected
with scrambled siRNA stained positive for Annexin V. A4A8RPA32-expressing cells did not exhibit Annexin V staining at
24 hours in response to HU treatment (Fig. 6A, middle row,
right panel). By 48 hours, approximately 50% of the wild-type
and uninfected cells were positive for both propidium iodide
(PI) and Annexin V staining, whereas A4A8-RPA32 cells had
only a modest increase in PI/Annexing V staining (8.7%, Fig.
6A, bottom row). The apoptotic fraction exhibited at 72 hours
in A4A8-RPA32 cells continued to appear suppressed and
delayed, suggesting a role for S4S8 phosphorylation in
apoptotic signaling (Fig. 6B).
Discussion
In this study, we have enhanced our understanding of the
interaction between RPA, ATR and the MRN complex, and
their respective roles in the replicative-stress-induced DNAdamage response. ‘Replicative stress’ generally refers to the
physical impairment and uncoupling of DNA helicases and
polymerases by DNA lesions, which leads to stalled replication
forks and long stretches of ssDNA. We observed foci that were
positive for hyperphosphorylated RPA in HU-induced DNA
damage, suggesting that hyperphosphorylation of RPA is
involved in the stabilization and repair of stalled forks.
Evidence has been provided that phosphorylation of NBS1
is required for an efficient response to DNA damage; however,
the functional significance of NBS1 phosphorylation is not
fully understood. In our study, we show that phosphorylation
of NBS1 is crucial for hyperphosphorylation of RPA in
response to HU-induced DNA damage. Cells with impaired
NBS1 phosphorylation had decreased hyperphosphorylation of
RPA following HU treatment, without affecting overall RPA
chromatin retention. These findings suggest a requirement of
NBS1 phosphorylation for the hyperphosphorylation of RPA.
One possibility is that the lack of RPA phosphorylation
observed in NBS1 phospho-mutant cells is unique to RPA.
However, it has previously been demonstrated that NBS1
phosphorylation is required for SMC1 phosphorylation and
CHK2 phosphorylation, following low-dose ionizing radiation
(IR) treatment, suggesting other DNA-damage response
proteins are affected by a lack of NBS1 phosphorylation
(Buscemi et al., 2001; Yazdi et al., 2002). However, not all
DNA-damage response proteins are impaired by the lack of
NBS1 phosphorylation. In NBS1 phospho-mutant cells, ATM
activation is not affected following IR and NBS1
phosphorylation is not required for UV-induced CHK1
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phosphorylation (Jazayeri et al., 2006). This suggests that some
proteins are impaired, whereas others are not affected by NBS1
phosphorylation following various types of DNA damage.
Based on our finding that expression of kinase-dead ATR
suppressed RPA hyperphosphorylation and that ATR retention
on chromatin is dependent on the presence of fully functional
NBS1, we propose that RPA hyperphosphorylation requires an
NBS1-dependent retention of ATR to the damaged site. A
similar model in which the kinase has a non-catalytic docking
site that helps to retain it in close proximity to its target proteins
has been observed previously in other signaling pathways. For
example, mitotic phosphorylation of NIR2 (PITPNM1)
provides a docking site for the PLK1 kinase involved in
cytokinetic events of cell division (Litvak et al., 2004).
ATR retention in NBS1 phospho-mutant cells appeared to
be decreased in the absence of HU, suggesting that NBS1
might be equally as important for ATR chromatin retention
during normal replication. It has been shown that ATR is
crucial for replication through ‘slow zones’ and prevents
double-strand-break accumulation during normal replication
(Cha and Kleckner, 2002; Trenz et al., 2006). This requirement
of NBS1 phosphorylation might help to explain the necessity

Fig. 6. Loss of S4S8
phosphorylation suppresses HUinduced apoptosis. (A) Time of
onset of apoptosis after 24 hours of
HU treatment (2 mM). HU-induced
apoptosis was assessed by Annexin
V staining and flow cytometry.
Right-hand quadrants indicate
Annexin-V-positive cells, indicative
of apoptosis. Cells in the upper
quadrants have begun to lose
membrane integrity and stain
positive for propidium iodide and
Annexin V. The results from one of
three representative experiments are
shown. (B) The percentage of
apoptotic cells was calculated from
at least three separate experiments.
The percentage is presented as the
mean ± s.d. of the total number of
gated cells in the upper- and lowerright quadrants. Following siRNA
downregulation of endogenous
RPA32, cells were treated with 2
mM HU for 24 hours. At the
indicated time points, cells were
harvested, fixed and stained with
Annexin V to detect apoptotic cells.

of both ATR and the MRN complex in preventing replication
stress during normal replication.
Our data, and previous studies, implicate ATR as the
primary kinase responsible for replicative-stress-induced
phosphorylation of RPA (Block et al., 2004; Peng and Chen,
2005). Members of the phosphoinositide 3-kinase related
kinases (PIKKs) – ATM, DNA-PK and ATR – have been
reported to hyperphosphorylate RPA. Each of these kinases
has been shown to phosphorylate RPA in vitro and in vivo
(Barr et al., 2003; Brush et al., 1994; Gately et al., 1998; Liu
et al., 2006; Oakley et al., 2001; Unsal-Kacmaz and Sancar,
2004; Wang et al., 2001). Recent reports have demonstrated
ATM-dependent activation of ATR in response to IR, and
ATR-dependent activation of ATM in response to HU and UV
(Jazayeri et al., 2006; Stiff et al., 2006). Why does HUinduced RPA hyperphosphorylation require NBS1 and ATR
but does not appear to require ATM even though ATM is
activated by replication stress? One explanation is that it
might be a matter of timing. With the initial stress in the form
of extended regions of ssDNA, increased binding of RPA
occurs and attracts ATR and ATRIP as the initial response.
NBS1, possibly through binding to ATRIP, appears to be
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necessary to retain the signal activation by RPA and ATR. This
does not rule out the possibility of a direct role for ATMdependent phosphorylation of RPA at later time points, as well
as an indirect role for ATM in the activation of downstream
kinases such as CHK2, which might contribute to the direct
phosphorylation of RPA in vivo.
Cells expressing alanine at S4 and S8 on the N-terminus of
RPA32 exhibited a loss of apoptosis. This suppression of
apoptosis might be attributable to a defect in the ability of a cell
to sense DNA damage and to activate the appropriate
downstream response, including apoptotic signaling. The
inability to induce apoptosis following DNA damage has the
potential to be advantageous to cancer cells. Indeed, studies have
shown that the loss of apoptosis contributes to tumorigenesis and
to the resistance of cancer cells to a variety of therapeutic agents
(Igney and Krammer, 2002; Lowe et al., 1993).
In conclusion, our findings provide novel evidence that fully
functional NBS1 is required for the hyperphosphorylation of
RPA present at DNA-repair-associated foci. Although
the function of NBS1 phosphorylation and RPA
hyperphosphorylation in protein interaction and protein
recruitment are only beginning to be understood, we have
shown that RPA hyperphosphorylation is involved in the
cellular response to DNA damage. Additional studies will be
needed to elucidate the relationship between ATR, RPA and
NBS1 in sensing DNA damage.
Materials and Methods
Cell lines and treatments
HeLa cells were obtained from the American Type Culture Collection (ATCC) and
maintained at 37°C and 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM)
(Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (HyClone,
South Logan, UT) plus 100 U/ml penicillin and 100 g/ml streptomycin. The
simian-virus-40-transformed NBS fibroblast cell line, NBS-ILB1, which had been
transfected with retroviral constructs encoding wild-type and phospho-mutant
NBS1 forms to generate the NBS-ILB1 (Vector), NBS-ILB1 (NBS1), NBS-ILB1
(S343A) and NBS-ILB1 (S278/S343A) cell lines were generously provided by
Patrick Concannon (Benaroya Research Institute, WA). Cells were grown in DMEM
supplemented with 15% fetal bovine serum, 100 U/ml penicillin, 100 g/ml
streptomycin and 500 g/ml G418 (Cerosaletti et al., 2000). ATR-kd mutant and
ATR-wt U2OS cells, kindly provided by Paul Nghiem (University of Washington
Medical Center, DC), were grown and maintained as previously described (Nghiem
et al., 2002). UM-SCC 38 cells were established at the University of Michigan and
generously provided by Thomas Carey (University of Michigan, MI). UM-SCC 38
cells expressing wild-type RPA 32 and S4A/S8A-substituted RPA32 were
maintained in DMEM containing 150 g/ml hygromycin (Sigma, St Louis, MO)
for selection. For retroviral packaging, Phoenix amphotrophic cells (Orbigen, San
Diego, CA) were grown in Dulbecco DMEM supplemented with 10% fetal bovine
serum with penicillin-streptomycin. For HU treatment, cells were incubated in
growth medium containing HU (1-5 mM) for the times indicated before harvesting.
To obtain cells primarily in S-phase, asynchronous cells were treated with 6 M
aphidicolin for 16-17 hours. The medium containing aphidicolin was removed, and
cells were washed twice in serum-free medium and then incubated in serum
containing medium for an additional 3 hours before treatment with HU. Where
indicated, cells were transfected with 50 nM of siRNA against RPA32 (5⬘-CCUAGUUUCACAAUCUGUUUU-3⬘, Dharmacon) using Lipofectamine RNAiMAX
(Invitrogen) in Opti-MEM I Reduced Serum Medium (Invitrogen) according to the
manufacturer’s instructions.

Retroviral gene expression
Wild-type and A4A8-substituted RPA32 cDNAs were inserted into the retroviral
vector pQCXIH (Clontech, Mountain View, CA). Amino acids 18-271 were
amplified from a pET-11d vector containing the RPA heterodimer (generously
supplied by Marc Wold, University of Iowa, IA) using primers 5⬘-GCGCACCGGTGATATACATATGTGGAAC-3⬘ and 5⬘-CGCGGGATCCGTAAGCTCAGTAATCTGGAACATCGTATGGGTATTCTGCATCTGTGGA-3⬘, and were digested
with BamHI and NaeI. Amino acids 1-18 were created by the ligation of two
phosphorylated, double-stranded oligonucleotides with AgeI and NaeI overhangs.
The N-terminal double-stranded oligonucleotides and the amplified C-terminus
containing a HA-tag sequence were ligated into AgeI/BamHI-digested pQCXIH.
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Phoenix A cells were plated in 60-mm culture dishes at 5⫻106 cells/ml and
transfected with 24 g of plasmid using Lipofectamine 2000 (Invitrogen). After 48
hours at 37°C, cells were incubated for an additional 24 hours at 32°C. Supernatants
were collected, centrifuged at 2000 g for 10 minutes and added to 25% confluent
SCC-38 cells in the presence of 10 g/ml polybrene (Sigma). After 48 hours, UMSCC-38 cells were selected with 150 g/ml hygromycin. Surviving cells were
grown to near confluence and tested for expression of recombinant RPA32 by
western blot analysis.

Western immunoblots
Cell lysates and immunoprecipitates were separated on 12% SDS-polyacrylamide
gels and transferred to polyvinylidene difluoride membranes. Membranes were
probed using primary antibodies against NBS1 (Novus Biological; 1:10,000),
NBS1-S(P)343 (phospho-specific) (Novus Biologicals; 1:7500), RPA32
(Neomarkers;
1:5000),
RPA32-S(P)4-S(P)8
(phospho-specific
for
hyperphosphorylated RPA32) (Bethyl Laboratories; 1:10,000), ATR (Genetex;
1:3000) and Orc2 (Genetex Inc.; 1:250). Secondary antibodies were Alexa-Fluor680-linked anti-rabbit and anti-mouse (Invitrogen; 1:5000), and bound antibodies
were visualized using infrared fluorescence (LI-COR, Lincoln, NE).

Peptide-mediated delivery of antibodies into HeLa cells

Chariot-antibody complexes were formed by incubating 2-3 g of anti-RPA32S(P)4-S(P)8, anti-NBS1, anti-NBS1-S(P)343 or negative control IgG with 4 g of
presonicated Chariot (Active Motif, Carlsbad, CA) in PBS (pH 7.4) for 30 minutes
at 25°C. HeLa cells were overlaid with the pre-formed complexes according to the
manufacturer’s recommendations. Briefly, the delivery of Chariot-antibody
complexes was performed by incubating complexes directly in cell medium with
cells for 3 hours at 37°C before mock or HU treatment.

Immunofluorescence microscopy
Cells were grown on 12-mm coverslips (BD Biosciences, Franklin Lakes, NJ) for
36 hours before treatment. Cells were treated with 4-5 mM HU for 3 hours. To
visualize extraction-resistant proteins, cells were washed with PBS containing 0.5%
Triton X-100 at RT for 10 minutes and fixed for 3 minutes with PBS containing 4%
paraformaldehyde. Cells were then blocked for 1 hour in PBS containing 15% fetal
bovine serum. Primary-antibody dilutions used are as follows: anti-RPA32-S(P)4S(P)8, 1:2000; anti-RPA70, 1:1000; anti-RPA32, 1:1000; and anti-NBS1-S(P)343,
1:1500. Secondary-antibody dilutions are as follows: anti-rabbit Alexa-Fluor-488,
1:300; and anti-mouse Alexa-Fluor-568, 1:300. Images were obtained with a Leica
confocal microscope (Leica Microsystems, Milton Keynes, UK) equipped with a
488/514 nm dual band argon ion laser. An oil-immersion objective was used. Images
were collected using Leica confocal software analysis package (TCS-NT) software.
For each experiment, at least 200 cells were analyzed, and experiments were
repeated three times. Quantification of fluorescence intensity was performed on
blind captured images using standardized capture settings, image processing and
analysis performed on Leica confocal software.

Subcellular fractionation
The cellular-protein fractionation protocol was performed as previously described
with slight modifications (Liu et al., 2001). Briefly, cells were treated with HU or
were mock-treated. The free cytoplasmic/nucleoplasmic fraction was prepared by
allowing cells to lyse for 10 minutes on ice in 0.5% Triton X-100 in cell lysis buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Nonidet P-40, 5 l/ml pepstatin,
5 g/ml leupeptin, 5 g/ml aprotinin, 10 mM NaF, 10 mM ␤-glycerophosphate, 1
mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride). The insoluble fraction was
washed with PBS and treated with 100 g/ml DNase I in cell lysis buffer containing
4 mM MgCl2 at 37°C for 15 minutes. The suspension was centrifuged, and the
supernatant was collected and designated the chromatin fraction.

Annexin V staining
Cells were stained using Annexin V staining kit (BD Biosciences), according to the
manufacturers instructions. Briefly, 5⫻105 cells were seeded on 60 mm plates and
treated with scrambled siRNA or siRNA directed towards endogenous RPA32 for
48 hours. Cells were washed and fresh medium was added for 3 hours. Cells were
then treated with HU (1 mM) for 24 hours. HU was removed from the medium and
replaced with fresh medium, and cells were collected at the indicated times. Floating
and adherent cells were washed twice in BD Perm/Wash buffer and resuspended in
Annexin V Binding Buffer (BD Biosciences) for 30 minutes. Annexin-V-positive
cells were detected with an Annexin-V–APC conjugate. PI was used to detect
necrotic cells as per the manufacturer’s instructions. Cells were analyzed for
apoptosis by flow cytometry with the BD FACSArray (BD Biosciences). Data were
analyzed using WinList (Verity Software) and Graph Pad Prism (Graph Pad
Software).
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Nbs1 is Required for RPA Phosphorylation Following
Replication Fork Stall and Collapse

Manthey, K., Elliott, J. and Oakley, G.G.
Supplemental Experimental Procedures

Peptide-mediated delivery of antibodies into HeLa cells.
Chariot®–antibody complexes were formed by incubating 2-3 µg of non-immune IgG, with 4 µg
of presonicated Chariot® (ChariotTM; Active Motif, Carlsbad, CA) in PBS (pH 7.4) for 30 min
at 25 ◦C. HeLa cells were overlaid with the pre-formed complexes according to the
manufacturer’s recommendations. Briefly, the delivery of Chariot®–antibody complexes was
performed by incubating Chariot®–antibody complexes directly in cell medium with cells for 3 h
at 37 ◦C.

Chariot-antibody Transformation Efficiency. To determine antibody transformation
efficiency, cell-associated fluorescence of a total of 10,000 cells was determined using flow
cytometry (FACSCalibur, BD Biosciences, Franklin Lakes, NJ). Chariot®–antibody treated cells
were fixed and permeabilized using the cytofix/ cytoperm kit (BD Biosciences) and stained with
Alexa Fluor 568 secondary antibody (Molecular Probes, Carlsbad, CA) at a 1:250 dilution.
Percentage of cells with Alexa Fluor 568 fluorescence was determined using CellQuest pro
software (BD Biosciences).

1

Flow cytometric analysis. HeLa cells were harvested at 0 hr, 18 hr, and 24 hr time points and
fixed with 70% ethanol. Approximately 106 cells/ml were incubated with propidium iodide and
RNase A, then analyzed using a FACSCalibur (BD Biosciences). Data was plotted using
CellQuest software; approximately 10,000 events were analyzed for each sample. To detect

H2AX phosphorylation mock- and HU-treated cells were fixed in 1% methanol-free
formaldehyde solution and permeabilized in 70% ethanol at -20°C over night. Cells were
washed in PBS, resuspended in 1% BSA in 0.1% Tween PBS (BSA-T-PBS) for 5 min
and incubated with 2µg/ml monoclonal γH2AX antibody (Upstate, Temecula, CA) over
night at 4°C. Cells were washed in BSA-T-PBS and suspended in BSA-T-PBS containing
10µg/mL goat anti-mouse secondary antibody (Alexa Fluor 647, Invitrogen). After 1h
incubation wash with BSA-T-PBS, cells were suspended in propidium iodide (PI)
staining solution containing 5 μg/mL PI (Sigma) and RNase A in PBS (100 mg/mL,
Sigma) and incubated for 30 min in the dark. The intensity of fluorescence was measured
with the BD FACSArray (BD Biosciences) and data were analyzed using WinList
(Verity) software.

Figure legends
Fig. S1. Transfection efficiency determined by flow cytometry. HeLa cells were
transfected with non-immune IgG isotype control, anti-RPA32S4PS8P or Nbs1 SP343
antibody-Chariot® complexes. Transfection efficiencies averaged approximately 80%.
The transfection efficiencies shown are 85% and 89% for anti-RPA32S4PS8P and Nbs1
SP343, respectively.
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Fig. S2. Cell cycle analysis following protein transfection with Chariot® reagent. HeLa
cells were mock-transfected or transfected with non-immune IgG-Chariot® complexes,
fixed at the indicated times and cell cycle analysis was performed.

Fig. S3. HU toxicity in NBS-ILB1 cells and transgenes following HU treatment. Cells
were treated with 5 mmol HU for 3 and 8 hours; for the 8 hour time point HU-containing
medium was replaced by regular medium after 3 hours and cells were incubated for
additional 5 hours. Cell survival was analyzed using the Live/Dead assay.

Fig. S4. H2AX and cell cycle analysis of cells either mock-treated or treated with HU
for 3 h. Bivariate analysis was performed with a BD-FACSArray demonstrating H2AX
phosphorylation predominantly in S-phase of HU-treated cells.
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